Fibroblast matrix implants-a better alternative for incisional hernia repair?

Area of Science:

• Biomaterials Science
• Regenerative Medicine
• Surgical Innovation

Background:

• Abdominal hernia repair using conventional prosthetic mesh has a high recurrence rate.
• There is a need for alternative mesh materials that promote better tissue integration and reduce recurrence.

Purpose of the Study:

• To evaluate a novel fibroblast matrix implant (FMI) as an alternative to conventional mesh for hernia repair.
• To assess the effect of human umbilical cord mesenchymal stem cell conditioned medium (hUC-MSC CM) on FMI performance in vitro and in vivo.

Main Methods:

• Developed a 3D poly-L-lactic acid scaffold coated with collagen and seeded with fibroblasts (FMI).
• Treated FMI with hUC-MSC CM and assessed fibroblast proliferation and collagen synthesis in vitro.
• Implanted four types of grafts (commercial mesh, cell-free matrix, FMI, FMI-CM) in a rat hernia model and evaluated cell growth, collagen deposition, and neovascularization over 28 days.

Main Results:

• In vitro studies showed hUC-MSC CM enhanced fibroblast collagen synthesis but did not significantly alter proliferation.
• In vivo, all matrices supported fibroblast growth and cell function for at least 1 month.
• The FMI-CM group exhibited the highest fibroblast count at 28 days, suggesting improved long-term integration.

Conclusions:

• Fibroblast matrix implant (FMI) combined with hUC-MSC CM demonstrates potential as an improved hernia repair material.
• This combination may offer enhanced reinforcement, potentially leading to reduced hernia recurrence rates.